Compare AREN & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AREN | TNYA |
|---|---|---|
| Founded | 2016 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.1M | 204.8M |
| IPO Year | N/A | 2021 |
| Metric | AREN | TNYA |
|---|---|---|
| Price | $4.29 | $1.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $12.00 | $8.60 |
| AVG Volume (30 Days) | 243.3K | ★ 2.4M |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.66 | N/A |
| Revenue | ★ $142,815,000.00 | N/A |
| Revenue This Year | $13.89 | N/A |
| Revenue Next Year | $13.81 | N/A |
| P/E Ratio | $6.68 | ★ N/A |
| Revenue Growth | ★ 6.72 | N/A |
| 52 Week Low | $1.05 | $0.36 |
| 52 Week High | $10.05 | $4.01 |
| Indicator | AREN | TNYA |
|---|---|---|
| Relative Strength Index (RSI) | 47.69 | 52.56 |
| Support Level | $3.93 | $1.21 |
| Resistance Level | $4.26 | $1.42 |
| Average True Range (ATR) | 0.33 | 0.10 |
| MACD | 0.08 | 0.02 |
| Stochastic Oscillator | 72.83 | 96.36 |
The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.